Home
Login Register
HanKore Env   

BIO-TREAT TECHNOLOGY LIMITED

 Post Reply 681-700 of 1050
 
teeth53
    16-Jan-2007 19:07  
Contact    Quote!
Wooww..Stuck at 78c still make alot , must learn from U not to be greedy, buy afew lot at a time for kopi $$$. :"))
 
 
chipchip66
    16-Jan-2007 18:41  
Contact    Quote!


Hi teeth53, i finally offloaded 8lots of my biot shares. From 2 lots at 78c to 8lots at average price of 66c. Finally out from my cold storage.cheersz!!
 
 
FearAndGreed
    16-Jan-2007 15:17  
Contact    Quote!


Seems water treatment is regaining institutional interest.   Goldman's Asia Water basket is up +8.1% so far this year outpacing the indices.   The popular press hasn't picked up on it yet but if the environmental stocks continue this outperformance it will become the topic du jour again. 

The new contract announcement isn't significant in size but it's the first such announcement since the corporate governance issues arose and suggests that business, at least, is not affected.  The bigger question may be financing risk.  BIOT is moving towards a more capital intensive BOT based business model and will is more dependent on the credit market and margins are likely to be pressured as they compete for projects in price-sensitive outlying regions. How do recent governance issues impact their funding rate?  I don't think it's a major concern as they have a history of successful operations so project finance should be low risk.

Did you see how the stock traded through .70?  There was almost no resistance and it became support quickly.  That suggests that there's a shortage of willing sellers down here.  My view:  bearish analysts (there's a couple) will need to rethink their price targets if they go underwater (should be happening soon) and the stock may rise ahead of their next earnings announcement from revisions, technical buying and lack of sellers.

I own shares from .53 and have been adding on the way up.  I am looking for the gap to fill before selling and will probably keep a core holding until 1.50.
 

 
iPunter
    14-Jan-2007 10:11  
Contact    Quote!


I agree muchly with Hulumas...



I also think Biotreat is no more on a downtrend and the chances of it dashing up are very high indeed. This is a good time to enter for a good punt, but if you do, you must dump it if it weakens by 10% or so.
 
 
jackjames
    13-Jan-2007 23:22  
Contact    Quote!
I just want to wait to clear my 4 lots at 0.845.. luckily I only bought 4 lots.. I will not want to keep this counter, no more! As for water treatment business, Hyflux is my choice.
 
 
Hulumas
    13-Jan-2007 14:47  
Contact    Quote!


Dear Readers,

Yes, I personally think the worst is over for Bio-treat, as for the rest price movement in the future, I leave the market mechanism to decide. Absolutely, no one knows.
 

 
jackjames
    12-Jan-2007 19:04  
Contact    Quote!
67RMB million not much lo... but , vested.
 
 
firebear
    12-Jan-2007 17:49  
Contact    Quote!
contract won at 67RMB
 
 
chipchip66
    08-Jan-2007 14:25  
Contact    Quote!
Got a feeling big boys have accumulated enuf of this baby!
 
 
chipchip66
    08-Jan-2007 14:23  
Contact    Quote!
Biot at 66.5c liao!
 

 
chipchip66
    08-Jan-2007 12:29  
Contact    Quote!
Looks like the micr0-ganisms have grown bigger and so is the share price. It is moving!
 
 
knightrider
    29-Nov-2006 00:09  
Contact    Quote!

BIO-TREAT TECHNOLOGY LIMITED SCRIP DIVIDEND SCHEME

[28 November 2006] - On 10 November 2006, the Board of Directors of Bio-Treat Technology Limited (the ?Company?) announced the notice of books closure date for the final dividend of 1.28 Singapore cents per share for the financial year ended 30 June 2006 (the ?2006 Final Dividend?) and informed that all Members who are entitled to 2006 Final Dividend will be eligible to participate in the Bio-Treat Technology Limited Scrip Dividend Scheme (the ?Scheme?) in respect of the 2006 Final Dividend, subject to the restrictions on Overseas Members.

Further to the aforesaid announcement, the Board of Directors of the Company is pleased to announce that for the purposes of the application of the Scheme to the 2006 Final Dividend, the issue price of the fully paid new ordinary shares of  HK$0.40 each in the capital of the Company (the ?New Shares?) to be issued to eligible Members who have elected to participate in the Scheme in respect of their holding of Shares, is S$0.57 for each New Share. The issue price of the New Shares represents the equivalent (as determined by the Directors of the Company) of 90% of the average of the last dealt prices of a Share on the Singapore Exchange Securities Trading Ltd (?SGX-ST?) for each of the three market days during the period commencing on the day on which the Shares are first quoted ex-dividend on the SGX-ST after the announcement of the 2006 Final Dividend and ending on 27 November 2006, being the Books Closure Date for the 2006 Final Dividend.28 November 2006] - On 10 November 2006, the Board of Directors of Bio-Treat Technology Limited (the ?Company?) announced the notice of books closure date for the final dividend of 1.28 Singapore cents per share for the financial year ended 30 June 2006 (the ?2006 Final Dividend?) and informed that all Members who are entitled to 2006 Final Dividend will be eligible to participate in the Bio-Treat Technology Limited Scrip Dividend Scheme (the ?Scheme?) in respect of the 2006 Final Dividend, subject to the restrictions on Overseas Members.

Further to the aforesaid announcement, the Board of Directors of the Company is pleased to announce that for the purposes of the application of the Scheme to the 2006 Final Dividend, the issue price of the fully paid new ordinary shares of  HK$0.40 each in the capital of the Company (the ?New Shares?) to be issued to eligible Members who have elected to participate in the Scheme in respect of their holding of Shares, is S$0.57 for each New Share. The issue price of the New Shares represents the equivalent (as determined by the Directors of the Company) of 90% of the average of the last dealt prices of a Share on the Singapore Exchange Securities Trading Ltd (?SGX-ST?) for each of the three market days during the period commencing on the day on which the Shares are first quoted ex-dividend on the SGX-ST after the announcement of the 2006 Final Dividend and ending on 27 November 2006, being the Books Closure Date for the 2006 Final Dividend.New Shares?) to be issued to eligible Members who have elected to participate in the Scheme in respect of their holding of Shares, is S$0.57 for each New Share. The issue price of the New Shares represents the equivalent (as determined by the Directors of the Company) of 90% of the average of the last dealt prices of a Share on the Singapore Exchange Securities Trading Ltd (?SGX-ST?) for each of the three market days during the period commencing on the day on which the Shares are first quoted ex-dividend on the SGX-ST after the announcement of the 2006 Final Dividend and ending on 27 November 2006, being the Books Closure Date for the 2006 Final Dividend.

 
 
knightrider
    22-Nov-2006 15:43  
Contact    Quote!
Once bitten, shy ler ! It will move a bit so as not to disappoint the market, I m still holding my lots at 0.69 !!!!
 
 
chipchip66
    22-Nov-2006 11:18  
Contact    Quote!
will it cheong like epure?
 
 
chipchip66
    22-Nov-2006 11:01  
Contact    Quote!
may move up again. will it test 65c?
 

 
chew8888
    21-Nov-2006 08:12  
Contact    Quote!
Do you think  Bio-Treat has hit the bottom, and recover??
 
 
chipchip66
    16-Nov-2006 14:47  
Contact    Quote!
going to move up again!
 
 
ihatcoy
    15-Nov-2006 12:15  
Contact    Quote!
Published November 14, 2006

Bio-Treat names probe team members

First-quarter profit slips 8.2% while revenue rises 9.7%

By MATTHEW PHAN





AIMING to restore investor confidence, controversy-hit Bio-Treat Technology yesterday named the members of an independent review task force and an inquiry committee to look at various matters.

Mr Wing: The inquiry committee will look into his allegations


The water-treatment group yesterday also released its first-quarter results, showing an 8.2 per cent fall in net profit.

Sparked by backlash from the investing community following Bio-Treat's lack of a profit warning preceding its poor FY2006 results in late August, the task force will review its internal controls and disclosure policies.

The inquiry committee will investigate allegations by Bio-Treat's former chairman Wing Hak Man that a resignation letter said to be from him was a forged one.

The task force comprises Phua Tin How as chairman and Jerry Yip Wai Leung and David Ong Mung Pang as members. Mr Phua (former president of DelGro and SBS Transit) and Mr Yip (chairman of Bio-Treat's audit, nominating and remuneration committees) are both Bio-Treat independent directors and Mr Ong is an advocate and solicitor of the Supreme Court of Singapore.,

The inquiry committee is chaired by Sajjad Akhtar, managing director of Corporate Advisory Partners. Its members are Lee Han Yang, a senior lawyer with over 30 years experience and a former chairman of Tibs Holdings, and Lim Soon Hock, former vice-president and managing director of Compaq Computer Asia Pacific and currently managing director of PLAN-B ICAG Pte Ltd.

Bio-Treat's earnings for its first quarter ended Sept 30 fell 8.2 per cent year-on-year to 61.9 million yuan. This was attributed to higher finance costs of 13.4 million yuan (S$2.65 million) due to notional interest expense on its convertible bond, and a 5.5 million yuan provision for foreign exchange loss due to the Hong Kong dollar weakening against the yuan.

Revenues rose 9.7 per cent year-on-year to 306.27 million yuan. Revenues from turnkey services dipped 4.2 per cent to 219.3 million yuan, while sales of Bio-Treat's BMS technology rose 30.6 per cent to 65.7 million yuan. The remaining 21.3 million yuan came from discharging fees from BOT/TOT projects.

The group's order book stands at 1.7 billion yuan, said its finance director Alan Lau, comparable to the level at end FY2006, when the book was bloated by project delays blamed on inclement weather. The group will catch up with its backlog of projects by the end of 2Q '07, and no projects have been cancelled, he said.

Bio-Treat is discussing project financing with banks but will not incur the debt until the funds are needed in 1H '08, and currently has no further equity financing plans, he said. The group had 602.62 million yuan in cash as of end Sept 2006.

Operating cash flow was a negative 30.64 million yuan in 1Q '07, versus a positive 155.72 million yuan in 1Q '06, due to working capital-related outflows for contracts work-in-progess and prepayments, deposits and other receivables.

---------------------------------------------------------------------
Bio-Treat also said the next reset date for the conversion price of some $206 million worth of convertible bonds is Jan 18, 2007. The conversion price will be calculated by the average closing price for the 30 working days prior to the reset date, but cannot go below a floor of 91 cents.


------------------------------------------------------------

Anyone knows the implication of what e last paragraph means??
 
 
nextdoor
    15-Nov-2006 12:03  
Contact    Quote!


Hi ipunter,

:-))

All the best!!
 
 
iPunter
    15-Nov-2006 11:47  
Contact    Quote!
Hi nextdoor,

Come on, lah...  you are really so humble, my friend ...

I can recognise a  sifu  when I see one!

Best Regards.   :)

-------------
 
Important: Please read our Terms and Conditions and Privacy Policy .